Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 29, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 at 8:40 a.m. ET at the Boston Marriott Copley Place, Massachusetts; the 24th Annual Roth Conference on March 12, 2012 at 4:00 p.m. PT at the Ritz Carlton Laguna Niguel, California; and the Barclays Capital Global Healthcare Conference on March 14, 2012 at 2:30 p.m. ET at the Loews Miami Hotel, Florida.

The live and archived webcasts of the company presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contacts:

Kelly Barry [phone] (media)

Teri Dahlman [phone] (investors)

SOURCE Idenix Pharmaceuticals, Inc.

Copyright 2012 PR Newswire